Literature DB >> 14990741

Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication.

Patrizia Caposio1, Michel Dreano, Gianni Garotta, Giorgio Gribaudo, Santo Landolfo.   

Abstract

Human cytomegalovirus (HCMV) exploits the host transcription factor NF-kappaB to enhance its own replication, dissemination, and reactivation from latency. Here we report that HCMV infection activates the upstream IkappaB kinase (IKK) complex and that its catalytic IKK2 subunit is required for HCMV-induced NF-kappaB activation, as well as the replication of different HCMV strains. These results indicate that IKK2 is essential for HCMV replication and emphasize the feasibility of blocking NF-kappaB activation as a way of inhibiting infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990741      PMCID: PMC353729          DOI: 10.1128/jvi.78.6.3190-3195.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Regulation of human cytomegalovirus gene expression.

Authors:  E A Fortunato; D H Spector
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

Review 3.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 4.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 5.  Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.

Authors:  E A Fortunato; A K McElroy; I Sanchez; D H Spector
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

6.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

7.  The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.

Authors:  A D Yurochko; E S Hwang; L Rasmussen; S Keay; L Pereira; E S Huang
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 promoter.

Authors:  G Gribaudo; S Ravaglia; L Guandalini; R Cavallo; M Gariglio; S Landolfo
Journal:  Virus Res       Date:  1996-11       Impact factor: 3.303

9.  Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.

Authors:  T F Kowalik; B Wing; J S Haskill; J C Azizkhan; A S Baldwin; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.

Authors:  A D Yurochko; T F Kowalik; S M Huong; E S Huang
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  19 in total

1.  Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.

Authors:  Montse Gustems; Eva Borst; Chris A Benedict; Carmen Pérez; Martin Messerle; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice.

Authors:  Charles H Cook; Joanne Trgovcich; Peter D Zimmerman; Yingxue Zhang; Daniel D Sedmak
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

4.  Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.

Authors:  Ian B DeMeritt; Jagat P Podduturi; A Michael Tilley; Maciej T Nogalski; Andrew D Yurochko
Journal:  Virology       Date:  2005-11-21       Impact factor: 3.616

5.  Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.

Authors:  Christian O Simon; Christof K Seckert; Doris Dreis; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  The IκB Kinases Restrict Human Cytomegalovirus Infection.

Authors:  Christopher M Goodwin; Joshua Munger
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

7.  UL26 Attenuates IKKβ-Mediated Induction of Interferon-Stimulated Gene (ISG) Expression and Enhanced Protein ISGylation during Human Cytomegalovirus Infection.

Authors:  Christopher M Goodwin; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

8.  SAMHD1 Modulates Early Steps during Human Cytomegalovirus Infection by Limiting NF-κB Activation.

Authors:  Eui Tae Kim; Kathryn L Roche; Katarzyna Kulej; Lynn A Spruce; Steven H Seeholzer; Donald M Coen; Felipe Diaz-Griffero; Eain A Murphy; Matthew D Weitzman
Journal:  Cell Rep       Date:  2019-07-09       Impact factor: 9.423

9.  The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating cells.

Authors:  Patrizia Caposio; Anna Luganini; Matteo Bronzini; Santo Landolfo; Giorgio Gribaudo
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

10.  The human cytomegalovirus UL26 protein antagonizes NF-κB activation.

Authors:  Chun Mathers; Xenia Schafer; Luis Martínez-Sobrido; Joshua Munger
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.